APA (7th ed.) Citation

Liu, X., Ping, G., Ji, D., Wen, Z., & Chen, Y. (2024). Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes. Biomedical Engineering & Computational Biology, 1. https://doi.org/10.1177/11795972241274024

Chicago Style (17th ed.) Citation

Liu, Xiangxiang, Guoqiang Ping, Dongze Ji, Zhifa Wen, and Yajun Chen. "Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes." Biomedical Engineering & Computational Biology 2024: 1. https://doi.org/10.1177/11795972241274024.

MLA (9th ed.) Citation

Liu, Xiangxiang, et al. "Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes." Biomedical Engineering & Computational Biology, 2024, p. 1, https://doi.org/10.1177/11795972241274024.